In February, 2023 Imara merged with Enliven therapeutics (ELVN), with the resulting firm retaining Enliven’s name and development pipeline. Enliven is a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors to help patients with cancer live not only longer, but better.
Boston, Massachusetts
Founded in 2016
11-50 employees
In February, 2023 Imara merged with Enliven therapeutics (ELVN), with the resulting firm retaining Enliven’s name and development pipeline. Enliven is a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors to help patients with cancer live not only longer, but better.
Company Information
- Industry
- Company Type
- Public Company
- Founded
- 2016
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- City
- Boston
- Region
- Massachusetts
- Postal Code
- Country
- United States
Web Presence
Websiteenliventherapeutics.com
LinkedIn0 followers
